IL-18 stimulates CSF-1 expression via MyD88-dependent pathway

Progress in Biochemistry and Biophysics

Volumn 38, Issue 4, 2011, Pages 311-319

  Xue, Yan ^a   Liu, Lin Lin ^a   He, Fen ^a   Jiang, Xue ^a   Zeng, Xian Lu ^a   Ba, Xue Qing ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

CSF 1; IL 18; MyD88; NF B

Indexed keywords

EID: 79955798349     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00471     Document Type: Article

References (44)

1. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev, 2002, 13 (4-5): 413-421
2. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res, 2008, 79(3):360-376
3. Leung B P, Culshaw S, Gracie J A, et al. A role for IL-18 in neutrophil activation. J Immunol, 2001, 167(5):2879-2886 (Pubitemid 32768922)
4. Barbulescu K, Becker C, Schlaak J F, et al. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol, 1998, 160(8):3642-3647 (Pubitemid 28176063)
5. Golab J. Interleukin 18 - interferon gamma inducing factor-a novel player in tumour immunotherapy?. Cytokine, 2000, 12(4):332-338 (Pubitemid 30449823)
6. Favilli F, Anzilotti C, Martinelli L, et al. IL-18 activity in systemic lupus erythematosus. Ann N y Acad Sci, 2009, 1173:301-309
7. Rothe H, Jenkins N A, Copeland N G, et al. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest, 1997, 99(3):469-474 (Pubitemid 27414804)
8. Sasaki Y, Yoshimoto T, Maruyama H, et al. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J Exp Med, 2005, 202(5):607-616 (Pubitemid 41248412)
9. Li Y, Ishii K, Hisaeda H, et al. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?. Gene Ther, 2004, 11(11):941-948 (Pubitemid 38786609)
10. Kawakami K, Koguchi Y, Qureshi M H, et al. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J Immunol, 2000, 165(2):941-947 (Pubitemid 30484762)
11. Thompson S R, Humphries S E. Interleukin-18 genetics and inflammatory disease susceptibility. Genes Immun, 2007, 8(2):91-99 (Pubitemid 46390906)
12. Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol, 1996, 156(11):4274-4279 (Pubitemid 26165826)
13. McInnes I B, Liew F Y, Gracie J A. Interleukin-18: a therapeutic target in rheumatoid arthritis?. Arthritis Res Ther, 2005, 7(1):38-41 (Pubitemid 40214526)
14. Liew F Y, Wei X Q, McInnes I B. Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis, 2003, 62 (Suppl 2): ii48-50
15. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature, 1995, 378(6552):88-91
16. Conti B, Park L C, Calingasan N Y, et al. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res, 1999, 67(1):46-52 (Pubitemid 29170067)
17. Puren A J, Fantuzzi G, Dinarello C A. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA, 1999, 96(5):2256-2261 (Pubitemid 29117901)
18. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol, 1998, 161(7):3400-3407
19. Muhl H, Pfeilschifter J. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur J Pharmacol, 2004, 500 (1-3): 63-71 (Pubitemid 39303997)
20. Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev, 2001, 12(1):53-72 (Pubitemid 32294587)
21. Stoll S, Jonuleit H, Schmitt E, et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol, 1998, 28(10):3231-3239 (Pubitemid 28470269)
22. Wei S, Dai X M, Stanley e R. Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death. J Leukoc Biol, 2006, 80(6):1445-1453 (Pubitemid 44904983)
23. Pixley F J, Stanley e R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol, 2004, 14(11):628-638 (Pubitemid 39440612)
24. Ji X H, Yao T, Qin J C, et al. Interaction between M-CSF and IL-10 on productions of IL-12 and IL-18 and expressions of CD14, CD23, and CD64 by human monocytes. Acta Pharmacol Sin, 2004, 25(10):1361-1365 (Pubitemid 39361810)
25. Chen C, Shang X, Cui L, et al. L-selectin ligation-induced CSF-1 gene transcription is regulated by AP-1 in a c-Abl kinase-dependent manner. Hum Immunol, 2008, 69(8):501-509
26. Ba X Q, Chen C X, Xu T, et al. Engagement of PSGL-1 upregulates CSF-1 transcription via a mechanism that may involve Syk. Cell Immunol, 2005, 237(1):1-6 (Pubitemid 41821076)
27. Ladner M B, Martin G A, Noble J A, et al. Human CSF-1: gene structure and alternative splicing of mRNA precursors. EMBO J, 1987, 6(9):2693-2698
28. Das S K, Stanley e R. Structure-function studies of a colony stimulating factor (CSF-1). J Biol Chem, 1982, 257(22):13679-13684 (Pubitemid 13187129)
29. Stanley e R, Berg K L, Einstein D B, et al. The biology and action of colony stimulating factor-1. Stem Cells, 1994, 12 (Suppl 1):15-24; 25
30. Loiarro M, Capolunghi F, Fanto N, et al. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol, 2007, 82(4):801-810 (Pubitemid 47511039)
31. Wang M, Markel T A, Meldrum D R. Interleukin 18 in the heart. Shock, 2008, 30(1):3-10
32. Kenny e F, O'Neill L A. Signalling adaptors used by Toll-like receptors: an update. Cytokine, 2008, 43(3):342-349
33. Kitaura H, Zhou P, Kim H J, et al. M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest, 2005, 115(12):3418-3427 (Pubitemid 43121830)
34. Wiktor-Jedrzejczak W, Dzwigala B, Szperl M, et al. Colonystimulating factor 1-dependent resident macrophages play a regulatory role in fighting Escherichia coli fecal peritonitis. Infect Immun, 1996, 64(5):1577-1581 (Pubitemid 26129818)
35. Gibbons R, Ross F P, Perkins S L, et al. Interleukin-4 enhances murine bone marrow macrophage M-CSF receptor expression by a posttranscriptional mechanism. Lymphokine Cytokine Res, 1994, 13(2):85-92 (Pubitemid 24136347)
36. Liang Y, Zhou Y, Shen P. NF-kappaB and its regulation on the immune system. Cell Mol Immunol, 2004, 1(5):343-350
37. Rajavashisth T B, Yamada H, Mishra N K. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B. Arterioscler Thromb Vasc Biol, 1995, 15(10):1591-1598
38. Harrington M, Konicek B W, Xia X L, et al. Transcriptional regulation of the mouse CSF-1 gene. Mol Reprod Dev, 1997, 46(1):39-44; 44-35
39. Yamada H, Iwase S, Mohri M, et al. Involvement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. Blood, 1991, 78(8):1988-1995
40. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol, 2009, 27:693-733
41. Martin M U, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta, 2002, 1592(3):265-280 (Pubitemid 35284883)
42. Subramaniam S, Stansberg C, Cunningham C. The interleukin 1 receptor family. Dev Comp Immunol, 2004, 28(5):415-428 (Pubitemid 38177445)
43. O'Neill L A, Bowie A G. The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat Rev Immunol, 2007, 7(5):353-364 (Pubitemid 46674493)
44. Loiarro M, Sette C, Gallo G, et al. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B. J Biol Chem, 2005, 280(16):15809-15814 (Pubitemid 40616701)